$147.69
-12.31 (-7.69%)

Key Metrics

Market Cap
$157.02M
P/E Ratio
-4.92
EPS
$-0.30
Beta
N/A
Dividend Yield
N/A
ROE
-22.12%
Current Ratio
12.39

Company Information

Industry
Medical Devices

About MaxCyte Inc

MaxCyte Inc a global life sciences company engages in the discovery development and commercialization of nextgeneration cell therapies Its products include ExPERT ATx a static electroporation instrument for small to medium scale transfection ExPERT STx a flow electroporation for protein production and drug development as well as expression of therapeutic targets for cellbased assays ExPERT GTx a flow electroporation for large scale transfection in therapeutic applications and ExPERT VLx for very large volume cellengineering The company also provides disposable processing assemblies PAs to process and electroporate cells and accessories supporting PAs such as electroporation buffer solution and software protocols The company was incorporated in 1998 and is headquartered in Rockville Maryland

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2025-05-07 $-0.10 $-0.10 +-6.3%
2025-03-11 $-0.08 $-0.11 +-24.8%
2024-11-06 $-0.08 $-0.13 +-35.2%
2024-08-06 $-0.07 $-0.10 +-27.4%

Financial Ratios (TTM)

Gross Margin
79.79%
Operating Margin
-149.57%
Net Margin
-125.22%
ROA
-20.37%
Price to Book
1.09
Price to Sales
5.82